Spots Global Cancer Trial Database for vaginal neoplasms
Every month we try and update this database with for vaginal neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Impact of the COVID-19 Pandemic in Gynecological Oncology | NCT04351139 | Gynecologic Can... Breast Neoplasm... Uterine Neoplas... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... | modification of... | 18 Years - | Hospices Civils de Lyon | |
Questionnaire Study for Gynecological Cancer Survivors | NCT00391664 | Endometrial Neo... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Genital Neoplas... | Psychosocial | 20 Years - 75 Years | Walter Reed Army Medical Center | |
Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) | NCT03546842 | Papillomavirus ... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Adenocarcinoma ... Condylomata Acu... | 9vHPV vaccine | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy | NCT00112307 | Cervix Neoplasm... Uterine Neoplas... Vaginal Neoplas... Vulvar Neoplasm... | Brachytherapy | 18 Years - | Brigham and Women's Hospital | |
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | NCT01654458 | Sexual Dysfunct... Uterine Cervica... Ovarian Neoplas... Uterine Neoplas... Genital Neoplas... | GyneGals Suppor... | 18 Years - | Women's College Hospital | |
Impact of the COVID-19 Pandemic in Gynecological Oncology | NCT04351139 | Gynecologic Can... Breast Neoplasm... Uterine Neoplas... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... | modification of... | 18 Years - | Hospices Civils de Lyon | |
Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) | NCT03546842 | Papillomavirus ... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Adenocarcinoma ... Condylomata Acu... | 9vHPV vaccine | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) | NCT00188578 | Cervix Neoplasm... Uterine Neoplas... Vaginal Neoplas... | Intensity Modul... | 18 Years - | University Health Network, Toronto | |
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | NCT01654458 | Sexual Dysfunct... Uterine Cervica... Ovarian Neoplas... Uterine Neoplas... Genital Neoplas... | GyneGals Suppor... | 18 Years - | Women's College Hospital | |
Peritoneum Vaginoplasty; Implementation According to IDEAL Framework | NCT05925361 | Rokitansky Kust... Vaginal Neoplas... Gender Incongru... Vaginal Obstruc... Penoscrotal Hyp... | Laparoscopic pe... | 18 Years - | Amsterdam UMC, location VUmc |